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Abstract
Although mitochondrial dysfunction has been observed in various types of human cancer cells, the molecular mechanism
underlying mitochondrial dysfunction mediated tumorigenesis remains largely elusive. To further explore the function of
mitochondria and their involvement in the pathogenic mechanisms of cancer development, mitochondrial dysfunction
clones of breast cancer cells were generated by rotenone treatment, a specific inhibitor of mitochondrial electron transport
complex I. These clones were verified by mitochondrial respiratory defect measurement. Moreover, those clones exhibited
increased reactive oxygen species (ROS), and showed higher migration and invasive behaviors compared with their parental
cells. Furthermore, antioxidant N-acetyl cysteine, PEG-catalase, and mito-TEMPO effectively inhibited cell migration and
invasion in these clones. Notably, ROS regulated malignant cellular behavior was in part mediated through upregulation of
hypoxia-inducible factor-1 a and vascular endothelial growth factor. Our results suggest that mitochondrial dysfunction
promotes cancer cell motility partly through HIF1a accumulation mediated via increased production of reactive oxygen
species.
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Introduction
Cancer cells display mitochondrial dysfunction to make cells
adapt glycolysis to generate ATP even in the presence of oxygen,
namely Warburg effect [1]. The mitochondrial dysfunction has
been found to be associated with the development of human
cancers [2], [3]. It has been reported that mitochondrial
dysfunction could be caused by inhibitors of mitochondrial
electron transport chain [4], pathogenic mutations in mitochon-
drial DNA (mtDNA) [3], and mutations in nuclear gene coded
electron transport chain proteins [2]. Additionally, accumulating
evidence suggests that cancer cells exhibit increased intrinsic
reactive oxygen species (ROS) stress partly due to mitochondrial
malfunction [5], [6]. The increased ROS in cancer cells may in
turn affect certain redoxsensitive molecules and further lead to
stimulation of cellular proliferation, cell migration and invasion,
contributing to carcinogenesis [7], [8]. However, the underlying
molecular mechanisms by which mitochondrial dysfunction
increases ROS production and subsequently leads to tumorigen-
esis are not fully understood.
Emerging evidence suggests that mitochondrial malfunction and
hypoxia in the tumor microenvironment are considered as two
major factors contributing to the Warburg effect [9], [10]. In solid
tumors, hypoxia, which is an oxygen tension below physiologic
levels, develops as abnormal proliferation outstrips the blood
supply [11]. This hypoxic region is involved in tumor malignancy
and proliferation, resulting in the development of resistance to
radiotherapy [12]. Hypoxia-inducible factor-1 (HIF-1), a tran-
scription factor that regulates the cellular response to hypoxia,
induces several genes that mediate tumorigenesis [13], [14]. It is
known that HIF-1 is a heterodimer that consists of the oxygen-
sensitive HIF-1a subunit and the constitutively expressed HIF-1b
subunit [15], [16]. Under normoxic conditions, HIF-1a is
hydroxylated by prolyl hydroxylases on the proline residues in
the oxygen-dependent degradation domain [17], [18]. In hypoxic
conditions, low oxygen leads to HIF-1a stabilization due to the
inhibition of prolyl-hydroxylation and subsequent reduction in
HIF-1a ubiquitination and degradation [18].
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In addition to the regulation of HIF-1a by oxygen supply, there
are also different HIF activators that include growth factors,
hormones, cytokines and viral proteins [19]. Interestingly, related
observations of ROS regulating HIF-1a expression appear to be
controversial. For example, multiple studies have shown that
increased HIF-1a expression contributes to mitochondrial activity
and ROS formation during hypoxia [20], [21]. However, other
studies have demonstrated a decrease in HIF-1a with increasing
ROS [22]. Moreover, some studies have shown no effects on
mitochondrial ROS [23]. These controversy results suggest that
further study is required to investigate the relationship between
HIF-1 a and ROS.
In the present study, we treated SKBR3 and 4T1 breast cancer
cells by an inhibitor of mitochondrial electron transport complex I,
rotenone, for 1–2 weeks to establish mitochondrial dysfunction
subclones. Each subclone was confirmed to have mitochondrial
dysfunction by measurement of oxygen consumption, glucose
uptake, and lactate production. We found that mitochondrial
dysfunction subclones had elevated levels of ROS production. We
further analyzed (a) whether ROS are required for induction of
tumor cell migration and invasion; (b) whether ROS production
regulate HIF-1a and vascular endothelial growth factor (VEGF)
expression; (c) whether ROS govern tumor cell migration and
invasion through the regulation of HIF-1a and VEGF expression.
This work provides the molecular insight into the role of ROS in
the regulation of breast cancer cell migration and invasion.
Materials and Methods
Reagents
Antibody against HIF-1a was purchased from BD Biosciences.
Antibodies against VEGF and b-actin were purchased from Santa
Cruz Biotechnology. Rotenone, PEG-catalase, and antioxidant N-
acetyl cysteine were obtained from Sigma. 29,79-Dichlorofluor-
escein diacetate (CM2-DCFHDA) was purchased from Invitrogen.
mitoTEMPO was purchased from Enzo Life Sciences. 8 mm pore
Transwell inserts and Matrigel were bought from BD Biosciences.
Cell Culture
SKBR3 and 4T1 breast cancer cells were bought from
American Type Culture Collection (Rockville, MD). SKBR3 cells
were cultured in DMEM medium supplemented with 10% fetal
bovine serum and penicillin (100 units/ml) and streptomycin
(100 mg/ml). Murine 4T1 breast cancer cells were cultured in
1640 medium supplemented with 10% fetal bovine serum and
penicillin (100 units/ml) and streptomycin (100 mg/ml). The
Figure 1. Biochemical characterization of mitochondrial dysfunction of both clones of breast cancer cells. A, Comparison of ATP
synthase (left), glucose uptake (middle), and lactate production (right) in SKBR3 cells. *P,0.01 vs SKBR3 cells, **P,0.05 vs SKBR3 cells, #P,0.05 vs
SKBR3 cells (n = 3). B, Comparison of ATP synthase (left), glucose uptake (middle), and lactate production (right) in 4T1 cells. *P,0.05 vs 4T1 cells,
**P,0.01 vs 4T1 cells, #P,0.05 vs 4T1 cells (n = 3).
doi:10.1371/journal.pone.0069485.g001
Mitochondrial Dysfunction Increases ROS/HIF1a
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Figure 2. Effect of ROS on migration and invasion capacity of subclones and their parental cells by transwell assay. A, SKBR3
subclones migrated faster than parental SKBR3 cells. NAC was able to effectively inhibit the migration of SKBR3 subclones. *P,0.05 vs SKBR3 cells,
**P,0.01 vs A clone, #P,0.01 vs B clone (n = 3). B, 4T1 subclones migrated faster than parental 4T1 cells. NAC was able to effectively inhibit the
migration of 4T1 subclones. *P,0.05 vs 4T1 cells, **P,0.01 vs C clone, #P,0.01 vs D clones (n = 3).
doi:10.1371/journal.pone.0069485.g002
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subclone cells used in this study were generated by rotenone
treatment as described previously [4]. It is important to note that
rotenone was absent after clone generation during the clone
studies. Briefly, cells were treated for 24 h with rotenone
(100 nmol/L), then cultured in drug-free medium for 48 h.
Followed by two more cycles of rotenone treatment, cells were
then plated at a density of 200 per dish in drug-free medium to
allow the formation of colonies, which caused an increase in
superoxide generation measured by flow cytometry. Among these
clones, two clones with higher ROS from SKBR3 cells were
named as A and B, and two clones with higher ROS from 4T1
cells were marked as C and D for further studies.
ROS Measurement
Intracellular ROS generation was assessed using 29,7,-dichloro-
fluorescein diacetate. Briefly, 16106 cells were plated on the 6-well
plates and incubated with DCFH-DA (10 mmol/L) for 30 min at
37uC. Cells were washed and harvested in Hank’s buffered salt
solution (HBSS) and analyzed immediately using a BD FACScan
flow cytometer. Data were analyzed as single parameter frequency
histogram using cell Quest software (BD Biosciences). Results are
presented as mean fluorescence intensity.
Hydrogen Peroxide Measurement
The cells were lysed in 100 ml lysis buffer supplied by the H2O2
assay kit (Beyotime Institute of Biotechnology, China) to determine
the intracellular H2O2 concentration. The supernatants were
obtained by centrifuging at 12,0006g for 10 min. The H2O2
Figure 3. The migration capacity of subclones and their parental cells was measured by wound healing assay. A–B, The subclones
migrated faster than the parental cells SKBR3 cells (A) and 4T1 cells (B). NAC was able to effectively inhibit the migration of the subclones.
doi:10.1371/journal.pone.0069485.g003
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Figure 4. PEG-catalase and mito-TEMPO inhibited migration and invasion in subclone cells. A, The H2O2 concentrations were measured
in subclone cells treated with NAC. *P,0.01 vs control in A clone, **P,0.01 vs control in B clone, #P,0.01 vs control in C clone, ##P,0.05 vs
control in D clones (n = 3). B, Wound healing assay was conducted to measure the migration capacity of A subclone cells treated with 100 mM H2O2,
200 units/ml PEG-catalase, 25 nM mito-TEMPO, respectively. Images were captured at 24 h after wounding. C, Migration assay was performed in A
subclone cells treated with indicated reagents. D, Invasion capacity of A subclone cells treated with indicated reagents was detected by transwell
assay.
doi:10.1371/journal.pone.0069485.g004
Mitochondrial Dysfunction Increases ROS/HIF1a
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concentrations were measured with the assay kit according to the
manufacturer’s instructions [24]. Briefly, 50 ml sample solution
was incubated with 100 ml reaction solution at room temperature
for 30 min, and then the absorption at 560 nm was measured.
The H2O2 concentration was calculated by the standard curve
made from the standard solutions.
Mitochondrial Respiratory Defect Measurement
ATP measurements were performed using ATP assay Kit
(Beyotime). We also investigated the mitochondrial oxidative
phosphorylation contribution on ATP production with the
addition of ATP synthase inhibitor, oligomycin, as previously
described [25]. Briefly, cells were grown to approximately 80%
confluence, and then incubated in DMEM containing the
following combinations of substrates and inhibitors: 4.5 mg/ml
glucose plus 110 mg/l pyruvate; glucose plus 15 mg/ml of
oligomycin. Cells were incubated with 15 mg/ml of oligomycin
for 20 min before harvesting. The remaining steps were following
the manufacturer’s instructions.
Cellular glucose uptake was measured by incubating cells in
glucose-free medium with 0.2 Ci/mL [3H] 2-deoxyglucose
(specific activity, 40 Ci/mmol) for 60 minutes. After the cells
were washed with ice-cold PBS, the radioactivity in the cell pellets
was quantified by liquid scintillation counting. Cellular lactate
level was measured under normoxia with lactate assay kit
(Biovision) following the manufacturer’s instructions. The absor-
bance was recorded using a microplate reader at a 570-nm
wavelength. The data were normalized to the control group.
Transwell Migration and Invasion Assays
The migration of breast cancer cells and their subclones was
performed using a 24-well transwell chamber (Corning) containing
gelatin-coated polycarbonate membrane filter (6.5 mm diameter,
8 mm pore size). 16105 cells suspended in 100 ml culture medium
with 1% FBS were seeded into the upper chamber. The lower
chamber contained 600 ml culture medium with 10% FBS as a
chemoattractant. After 24 h incubation at 37uC in 5% CO2, non-
migrated cells were scraped from the upper surface of the
membrane with a cotton swab, and migrated cells remaining on
the bottom surface were fixed with 4% paraformaldehyde, staining
with giemsa and photographed under a microscope at 20
magnification. The numbers of migrated cells were counted under
a light microscope in 5 randomly-selected fields for each chamber.
The invasion of the cancer cells were performed by the same
procedure as in the migration assay except that the chamber filter
were coated with matrigel (BD Biosciences) and 56105 cells were
seeded into the upper chamber.
Wound Healing Assay
26105 cells were added to each well of 6-well plate and cultured
at 37uC in 5% CO2 until more than 80% confluent. They were
then scratched with a standard 200 ml pipette tip, wounded
monolayers were washed twice to remove nonadherent cells and
images were captured at 0 h, 24 h and 48 h after wounding using
a Nikon Eclipse TE300 microscope and a Nikon Plan Fluor
460.13 objective.
Figure 5. ROS promoted HIF-1a and VEGF expression in subclone cells. A, ROS led to increased expression of HIF-1a and VEGF in SKBR3
subclones. SKBR3 subclones showed higher normoxic and hypoxic HIF-1a level than the parental SKBR3 cells. VEGF expression was more increased in
SKBR3 subclones than in the parental SKBR3 cells. HIF-1a and VEGF expression in SKBR3 subclone were significantly inhibited by NAC. B, ROS led to
increased expression of HIF-1a and VEGF in 4T1 subcloneswhereas NAC was able to attenuate the ROS induced expression of HIF-1a and VEGF. C–D,
H2O2 promoted HIF-1a expression, while PEG-catalase and mito-TEMPO inhibited HIF-1a expression in A clone (C) and C clone (D).
doi:10.1371/journal.pone.0069485.g005
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Western Blotting Analysis
Western blotting was performed as previously described [26].
Briefly, cells were lysed with a whole-cell extract buffer (50 mM
Tris, 150 mM NaCl, 0.1% sodium dodecylsulfate, 5 mM EDTA,
4 mg/ml glycerophosphate) containing freshly protease inhibitors.
Total proteins were collected by centrifugation. The proteins were
quantified by BCA protein assay. Twenty-five micrograms of
lysate proteins were separated by SDS–PAGE and subsequently
transferred to a PVDF membrane. The membranes were blocked
with a solution of Tris-buffered saline (TBS), 0.1% Tween-20
(TBS-T) containing 5% nonfat milk. The membranes were
incubated overnight at 4uC with primary antibodies against
human HIF-1a, VEGF, and b-actin. The membranes were
washed with TBS-T, and secondary antibodies were added to
the membrane for 1 h at 37uC. Membranes were washed with
TBS-T, visualized with ECL reagent (Millipore), and exposed to
film.
RNAi-mediated Inhibition of HIF-1a
The target sequence of HIF-1a was selected [27] as followed:
59-TACGTTGTGAGTGGTATTATT-39. The 21 nt target se-
quence served as the basis for the design of the two complemen-
tary 55-mer siRNA template oligonucleotides that were synthe-
sized, annealed, and ligated annealed siRNA template were
inserted into the pSilencer 4.1-CMV vecter (Ambion). Briefly,
shRNA was designed by using the siRNA software according to
the sequence target as follows: Forward oligo, 59-GAT CCC GTT
GTG AGT GGT ATT ATT TTC AAG AGA AAT AAT ACC
ACT CAC AAC GTA A-39, Reverse oligo, 59-AGC TTT ACG
TTG TGA GTG GTA TTA TTT CTC TTG AAA TAA TAC
CAC TCA CAA CGG-39. The double stranded DNA sequence
was obtained through annealing after chemosynthesis and was
inserted into PsilencerTM4.1-CMV vector. The insert production
was transformed into E. coli cells. Then the clones were picked and
sequenced to verify the inserts. Transient transfection was
performed using the Cationic lipid Lipofectamine2000 (Invitrogen)
with HIF-1a shRNA vector.
Results
Generation of Subclones with Higher ROS
Rotenone has been accepted as a blocker of the electron flow
through inhibition of complex I and subsequently causing an
increase in the production of superoxide due to electron flow
bifurcation [4]. Therefore, we used rotenone to increase superox-
ide generation which leads to subsequent induction of ROS stress
in SKBR3 and 4T1 cells. After three cycles of rotenone treatment,
cells were plated in drug-free medium to allow the formation of
colonies. After subclones are generated, each 18 subclones from
SKBR3 and 4T1 cells were picked to measure ROS level. Among
18 SKBR3 subclones, 15 subclones showed significantly higher
ROS production compared to their parental SKBR3 cells, 3
subclones showed almost the same ROS level as their parental
SKBR3 cells (data not shown). Among 18 4T1 subclones, 14
subclones have obviously higher ROS production than that of
their parental 4T1 cells, and 4 subclones showed no difference in
ROS production with their parental 4T1 cells (data not shown).
Four clones with highest ROS were selected for further studies.
Two SKBR3 cells’ subclones with higher ROS were named A and
B (Figure S1A), while C and D subclones were selected from
4T1cells (Figure S1B).
Subclones Exhibiting Mitochondrial Dysfunction
To determine whether increased ROS affect mitochondrial
dysfunction, we performed the mitochondrial respiratory defect
measurement. As illustrated in Figure 1A, both A and B clones
showed increased in glucose uptake and lactate production
compared to their parental SKBR3 cells (Fig. 1A). Moreover,
both A and B clones had similar total ATP content compared with
the parental SKBR3 cells: however; ATP synthesis sensitive to
oligomycin that assumed to be contributed by mitochondrial ATP
synthase further decreased in A and B clones compared with
parental SKBR3 cells (Fig. 1B). Similar results were found in 4T1
cells (Fig. 1B). These results suggest that up-regulation of glycolysis
was sufficient to compensate the decreased ATP generation in the
mitochondria.
ROS Promoted Cell Motility and Invasion
As ROS have been reported to be involved in tumor metastasis
[8], we tested the motility and invasive potential of each subclones.
Furthermore, to evaluate whether increased ROS were essential
for this process, cells were pretreated with the antioxidant N-acetyl
cysteine (NAC) before the Transwell assay and wound healing
assay. As we expected, four subclones exhibited greater motility
compared to their parental cells. More importantly, these
migration capacities were significantly inhibited by NAC
(Fig. 2A, 2B). Consistent with these results, we observed that
these subclones with higher ROS showed highly invasion capacity,
which can be inhibited by NAC (Figure S2). In agreement with the
Transwell assay, the wound healing assay showed significantly
accelerated wound closure in these subclone cells compared to
their parental cells after scratch assay (Fig. 3A, 3B). NAC
effectively inhibited the wound closure in these subclones
(Fig. 3A, 3B). These results indicated that the aggressive cellular
behaviors of subclones might be regulated by ROS.
Inhibition of ROS Generation Decreased Cell Motility and
Invasion
To further confirm whether ROS were increased in subclone
cells, we measured the H2O2 concentrations in these subclones
using the commercial assay kit [24]. As expected, we found that
H2O2 was increased in these subclones (data not shown), and NAC
significantly inhibited generation of H2O2 in subclones (Figure 4A).
Furthermore, H2O2 promoted cell migration and invasion, while
its scavenger PEG-catalase decreased cell migration and invasion
in subclone cells (Figure 4B, 4C, 4D, Figure S3), suggesting that
ROS play a role in cell motility and invasion. More importantly,
mitochondria-target SOD mimetic, mito-TEMPO [28] inhibited
migration and invasion in subclone cells (Figure 4B, 4C, 4D,
Figure S3).
ROS Induced HIF-1a and VEGF Expression
Next, we explore the molecular mechanism of ROS-mediated
migration and invasion. Since mitochondrial ROS production has
Figure 6. ROS promoted aggressive cellular behaviors by up-regulating HIF-1a expression. A, The sequence of inserts in the shRNA
vector clone. B, Cells with HIF-1a shRNA showed decreased HIF-1a expression compared with the control. C, Cells with HIF-1a shRNA showed
decreased migration ability compared with the control as documented by transwell migration assay. **P,0.05 vs A clone (n = 3) D, Cells with HIF-1a
shRNA showed decreased invasive capacity compared with the control as documented by transwell invasion assay. **P,0.05 vs A clone (n = 3) E,
Wound healing assay showed that cells with HIF-1a shRNA migrated slower than the control.
doi:10.1371/journal.pone.0069485.g006
Mitochondrial Dysfunction Increases ROS/HIF1a
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been implicated in the stabilization of HIF-1a during hypoxia
[20], we measured HIF-1a expression under both hypoxia and
normoxia conditions. As cobalt chloride (CoCl2) has been
accepted as a hypoxic mimetic agent, we used 500 mmol/L CoCl2
to treat cells for 30 minutes before the cells were lysed. As shown in
Figure 5, the subclones exhibited increased expression of HIF-1a
under normoxic and hypoxic conditions. NAC inhibited not only
normoxic HIF-1a expression but also hypoxic HIFa expression in
both subclones (Figure 5A, 5B). VEGF, a crucial angiogenic factor
for controlling angiogenesis and vasculature, is one of the most
prominent HIF-1 target genes. Therefore, we further measured
VEGF expression in these subclones. We found that these
subclones have increased expression of VEGF (Figure 5A, 5B).
We also observed that VEGF expression was significantly
decreased after NAC treatment in both subclones (Figure 5A,
5B). These results suggest that ROS could induce HIF-1a and
consequently leads to increased VEGF expression. To further
validate the role of ROS in regulation of HIF-1a, the subclone
cells were treated with PEG-calatase and mito-TEMPO, respec-
tively. We observed that H2O2 upregulated HIF-1a expression,
whereas both PEG-calatase and mito-TEMPO down-regulated
the expression of HIF-1a in subclone cells (Figure 5C, 5D). Taken
together, our findings demonstrated that ROS play a critical role
in cell migration and invasion partly through induction of HIF-1a.
ROS Promoted Cell Motility by Upregulation of HIF-1a
Expression
To determine the role of HIF-1a in ROS-mediated cell motility
and invasion, we constructed the expression vector of HIF-1a
small interfering RNA to silence HIF 1a expression. The
constructs were sequenced to confirm that there are no unwanted
mutations (Fig. 6A). The interfering effects were determined by
Western blotting analysis. HIF-1a protein expression was signif-
icantly inhibited by its shRNA transfection (Fig. 6B). Then we
measured cell mobility and invasion ability after depletion of HIF-
1a. The results indicate that HIF-1a shRNA transfected cells
significantly decreased cells mobility and invasive capacity
compared to control cells (Fig. 6C, 6D, 6E). Our results suggest
that rotenone initially generate mitochondrial dysfunction and
increased ROS production which, in turn, affect tumor cell
motility and invasive capacity by upregulation of HIF-1a
expression.
Discussion
Mitochondria possess many biological functions, including the
production of ATP, housing numerous biochemical reactions,
generating ROS, and governing apoptosis [29]. Numerous studies
have suggested that these mitochondrial processes may play
important roles in tumor initiation and progression [30], [31]. For
example, mitochondrial ROS have been implicated in malignant
cell transformation [32]. Moreover, it has been suggested that
mitochondrial ROS may be important in the maintenance of
malignant phenotype through regulation of HIF-1a [28]. In this
study, we tested the hypothesis that additional mitochondrial
alterations acquired after malignant transformation may increase
ROS production which will further contribute to cancer develop-
ment via ROS-dependent HIF-1a and VEGF pathways to
promote cancer cell migration and invasion.
To achieve our goal, we choose rotenone to induce mitochon-
drial dysfunction to investigate whether rotenone could induce
ROS production. Both subclones of breast cancer cells showed
higher ROS consistent with declined mitochondrial respiration
function, as suggested by decreased ATP generation through
oxidative phosphorylation, increased ATP generation through
glycolysis, higher glucose uptake and lactate production. These
subclones also exhibited increased cellular motility and ability to
invade through Matrigel. These malignant behaviors were
inhibited by the antioxidant NAC, PEG-Calatase, and mito-
TEMPO, indicating the important role of ROS, which is
associated with mitochondrial dysfunction.
Although some researchers investigated the role of ROS in
carcinogenesis, the exact mechanisms how ROS are involved in
tumorigenesis are unclear. Recently, a number of studies have
suggested that mitochondrial ROS are involved in the stabilization
and activation of HIF under hypoxic conditions [21]. It is known
that HIF-1a, which is induced by hypoxia, growth factors, and
oncogenes, plays a pivotal role in tumor growth and angiogenesis
[13]. ROS affect HIF-1a expression under gastric ischemic
conditions, suggesting that ROS can regulate HIF-1a expression
in gastric ischemia [33]. Moreover, increased ROS and ROS-
dependent stabilization of HIF under conditions of normal oxygen
tension have also been reported in cancer cells by suppression of
SdhB expression [20]. Furthermore, Xia et al. found that the
stabilization of HIF-1a via ROS generation led to the binding of
HIF-1a to the FoxM1 promoter, resulting in increased FoxM1
oncoprotein expression in hepatocellular carcinoma [34]. Recent-
ly, mitochondria-target antioxidant mito-TEMPO has been
demonstrated to inhibit redox-dependent HIF-1a-mediated can-
cer pro-survival signaling pathways [28]. Consistent with these
reports, our results clearly suggest that increased ROS production
is required for HIF-1a stabilization in the mitochondrial
dysfunction cells induced by rotenone, and these effects were
attenuated by antioxidant NAC, PEG-Calatase, and mito-TEM-
PO. Therefore, our study indicates that ROS promote breast
cancer progression, which is in part mediated through up-
regulation of HIF-1a expression in breast cancer cells.
Multiple studies have demonstrated that ROS regulate VEGF
expression in various human cancers [35]. For example, Xia et al.
reported that ROS regulate angiogenesis and tumor growth,
which is mediated through upregulation of VEGF [36]. Moreover,
Liu et al. found that ROS up-regulate VEGF and HIF-1a through
the activation of Akt and p70S6K in human cancer cells [37].
Interestingly, HIF-1a has been found to control VEGF in a variety
of human cancer cells [38], [39]. Notably, HIF-1a-mediated up-
regulation of VEGF is important in the switch to the angiogenic
phenotype during early tumorigenesis [40]. Therefore, these
findings suggest that ROS govern VEGF production which is in
part mediated through up-regulation of HIF-1a. In line with these
reports, we revealed that high levels of ROS production caused
elevated VEGF expression by regulating HIF-1a. Conversely, the
decrease of HIF-1a expression by ROS inhibitors suppressed
VEGF transcriptional activation. Taken together, our present
study suggests that mitochondrial dysfunction in breast cancer cells
with high ROS production promotes cell mobility and invasion
which is in part mediated through HIF-1a and VEGF. However,
further in-depth investigation is warranted to explore the
molecular insight into the role of ROS-mediated tumorigenesis
in vivo.
Supporting Information
Figure S1 ROS were measured in subclones by DCF-DA
method. A–B, comparison of ROS generation by parental
SKBR3 cells (A) and 4T1 cells (B), and their subclones as assessed
by using CM-H2DCF-DA measurement done by flow cytometry.
(TIF)
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Figure S2 Effect of ROS on migration and invasion
capacity of subclones and their parental cells by
transwell assay. A, The invasive capacity of SKBR3 subclones
was higher than the parental SKBR3 cells and was effectively
inhibited by NAC. B, The invasive capacity of 4T1 subclones was
higher than the parental 4T1 cells and was effectively inhibited by
NAC.
(TIF)
Figure S3 PEG-catalase and mito-TEMPO inhibited
migration and invasion in C subclone cells. A, The
migration capacity of C subclone cells treated with different
reagents was measured by wound healing assay. B, Migration
assay was performed in C subclone cells treated with indicated
reagents. C, Invasion capacity of C subclone cells treated with
indicated reagents was detected by transwell assay.
(TIF)
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